Nothing Special   »   [go: up one dir, main page]

Yoshimura et al., 2023 - Google Patents

The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis

Yoshimura et al., 2023

View HTML
Document ID
11900303011199577940
Author
Yoshimura T
Li C
Wang Y
Matsukawa A
Publication year
Publication venue
Cellular & Molecular Immunology

External Links

Snippet

Breast cancer is the most prevalent cancer worldwide, and metastasis is the leading cause of death in cancer patients. Human monocyte chemoattractant protein-1 (MCP-1/CCL2) was isolated from the culture supernatants of not only mitogen-activated peripheral blood …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Yoshimura et al. The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis
Zhou et al. Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
Mou et al. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8
Deng et al. CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
Wang et al. PDCD4 deficiency aggravated colitis and colitis-associated colorectal cancer via promoting IL-6/STAT3 pathway in mice
US11344601B2 (en) Tumor microenvironment-related target TAK1 and application thereof in inhibition of tumor
CN113215158B (en) circPTEN1 for tumor treatment target and diagnosis biomarker and application thereof
Takahashi et al. Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model
Zhu et al. IRX5 promotes colorectal cancer metastasis by negatively regulating the core components of the RHOA pathway
Ryu et al. Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine
JP2022505327A (en) Composition for treating gastric cancer containing SYT11 inhibitor as an active ingredient
Wu et al. The disbalance of LRP1 and SIRPα by psychological stress dampens the clearance of tumor cells by macrophages
Zhao et al. A novel microRNA-182/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer
Xu et al. DLEU2: a meaningful long noncoding RNA in oncogenesis
Xu et al. Oncostatin M/Oncostatin M Receptor Signal Induces Radiation-Induced Heart Fibrosis by Regulating SMAD4 in Fibroblast
Jiang et al. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway
JP2021113824A (en) Scirrhous gastric cancer therapeutic agent, and gastric cancer prognosis prediction method
Hu et al. m6A reader YTHDF3 triggers the progression of hepatocellular carcinoma through the YTHDF3/m6A‐EGFR/STAT3 axis and EMT
CN113832226B (en) Method for researching correlation between GNL3 and liver cancer development and application of GNL3 as liver tumor stem cell and liver cancer marker
Xie et al. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis
WO2020040186A1 (en) Agent using hsp47 inhibitor to suppress metastasis
Zhao et al. H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR‐141/ICAM‐1 and miR‐139/CXCR4 Axes
JP7510144B2 (en) Anticancer drugs and their uses
Kzhyshkowska et al. Targeting of TAMs: can we be more clever than cancer cells?
Zhu et al. Retracted: Bladder cancer‐associated transcript 2 contributes to nephroblastoma progression